Anti-Cytokeratin [PK110]
Invented by Karen Pulford from University of Oxford
Invented at University of Oxford
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151393 |
| Applications | IHC IF IP WB |
| Antigen/Gene or Protein Targets | Cytokeratins of 50-67 kDa |
| Reactivity | Human |
| Relevance | Keratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I keratin (keratins 9 to 23) and one type II keratin (keratins 1 to 8). Keratins demonstrate tissue and differentiation specific expression profiles. |
| Host | Mouse |
| Immunogen | Epidermal keratin |
| Subclass | IgG |
| Molecular Weight (kDa) | 50-67 |
| Myeloma Used | P3/NS1/1-Ag4.1 |
| Recommended Growing Conditions | RPMI 1640 + 10% FCS + penicillin (100U/ml) + streptomycin (100mg/l) + glutamine (2mM) + HAT |
| Notes | Ultroser G can be used at 1% if the cells are not growing well. |
| Research Area | Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction |
References: 2 entries
Gatter et al. 1985. J Clin Pathol. 38(12):1353-7. PMID: 3908491.
An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
Europe PMC ID: 3908491
Add a reference
References: 2 entries
Gatter et al. 1985. J Clin Pathol. 38(12):1353-7. PMID: 3908491.
An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
Add a reference
